Individualized Cadence Thresholds for Moderate-to-Vigorous Intensity in Obese Taiwanese Young Adults

March 12, 2025 updated by: TSUNG-LIN CHIANG, Chinese Culture University

Establishing Individualized Step Cadence Thresholds for Moderate-to-Vigorous Intensity in Taiwanese Obese Young Adults: a Cross-Sectional Study

This study aims to determine the step cadence thresholds for moderate-to-vigorous physical activity (MVPA) in obese young adults. It examines the relationship between body composition and step cadence required to achieve moderate-intensity physical activity (MPA, 3 METs), MPAyoung (4.8 METs), and vigorous physical activity (VPA, 6 METs).

Study Overview

Detailed Description

Background: This study examined the relationship between body composition and Moderate-to-Vigorous Physical Activity (MVPA) cadence in obese individuals and establish cadence thresholds for moderate-intensity physical activity (MPA) (3 metabolic equivalents [METs]), MPAyoung (4.8 METs), and vigorous physical activity (VPA) (6 METs).

Methods: This study recruited 48 obese young adults who did not regularly engage in exercise. Exclusion criteria included a history of smoking, hypertension, diabetes, cardiovascular or respiratory diseases, neuromuscular or musculoskeletal disorders, or any condition deemed unsuitable for exercise by a physician. The study protocol was approved by the Fu Jen University Institutional Review Board for Human Research (Approval Number: C105137). All participants were fully informed about the study procedures and provided written informed consent prior to participation.

Anthropometrics and Body Composition Measurements Participants arrived at the lab fasted for a minimum of 3 hours, abstained from exercise for 12 hours, avoided caffeine for 6 hours, and refrained from alcohol consumption for 12 hours. Data collection for each subject occurred during the morning hours, as close as possible to awakening from sleep (i.e., from 7:00 AM to 10:00 AM). Height was measured using a digital stadiometer accuracy nearest to ± 0.1 cm (Kongho-Super View, Kong Ho Instruments Co., Ltd., New Taipei, Taiwan). Body composition was assessed using bioelectrical impedance analysis (BIA) with the InBody 720 device (Biospace Co., Ltd., Seoul, South Korea). Skin resistance was measured through an eight-point tactile-electrode system at different frequencies (1 kHz, 5 kHz, 50 kHz, 250 kHz, 500 kHz, 1 MHz). Lean body mass and fat mass were determined from the impedance values using the manufacturer's regression equations, based on the principle that different tissues have varying water content and, consequently, different electrical conductivity 30. The components used in further analysis included weight, body mass index (BMI), body fat mass (BFM), body fat percentage (FAT), visceral fat area (VFA), and skeletal muscle mass (SMM).

Incremental Submaximal Exercise Testing Protocol Participants were instructed to refrain from vigorous exercise, smoking, and the consumption of caffeine-containing foods and beverages for 24 hours prior to the experiment. During the test, each participant was equipped with a gas analyzer (MetaMax 3B, Cortex, Leipzig, Germany) and a heart rate monitor (Polar H10, Electro Oy, Kempele, Finland). The protocol began with a 10-minute seated rest period to measure resting oxygen consumption. Subsequently, participants completed an incremental submaximal treadmill walking test consisting of five stages, with speeds set at 3.2, 4.0, 4.8, 5.6, and 6.4 km/h. Each stage lasted 5 minutes, and participants were instructed to maintain a natural walking pattern throughout the test. Oxygen consumption was continuously recorded during the exercise phases using the gas analyzer, while the total step count for each stage was captured using a video camera.

Study Type

Observational

Enrollment (Actual)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 11114
        • Chinese Culture University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of obese young adults aged approximately 20 years. Participants include both males and females, with a BMI classified as obese (≥27 kg/m²). The study aims to examine the relationship between step cadence and metabolic equivalents during walking.

Description

Inclusion Criteria:

  • Adults aged 19-21 years
  • BMI classified as obese (≥27 kg/m²)
  • Able to walk on a treadmill without assistance

Exclusion Criteria:

  • Presence of metabolic, cardiovascular, or musculoskeletal disorders
  • History of bariatric surgery
  • Current participation in structured exercise program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Obese Young Adults
This study includes 48 obese young adults, approximately 20 years old, with 28 males and 20 females.
all participants walking at increasing speeds on a treadmill

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Step Cadence Thresholds for Moderate-to-Vigorous Physical Activity in Obese Young Adults
Time Frame: Day 1
This study examines the step cadence thresholds required to achieve moderate-to-vigorous physical activity (MVPA) in obese young adults. The primary outcome measure is the step cadence corresponding to 3 METs (MPA), 4.8 METs (MPAyoung), and 6 METs (VPA), determined through indirect calorimetry during incremental treadmill walking.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2017

Primary Completion (Actual)

November 8, 2018

Study Completion (Actual)

November 8, 2018

Study Registration Dates

First Submitted

March 6, 2025

First Submitted That Met QC Criteria

March 12, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • No. 105-2815-C-034-028-H
  • 105-2815-C-034-028-H (Other Grant/Funding Number: National Science and Technology Council, Taiwan)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on treadmill walking

Subscribe